TWI339125B - Aqueous solution of ascorbic acid and method for producing same - Google Patents

Aqueous solution of ascorbic acid and method for producing same Download PDF

Info

Publication number
TWI339125B
TWI339125B TW092114028A TW92114028A TWI339125B TW I339125 B TWI339125 B TW I339125B TW 092114028 A TW092114028 A TW 092114028A TW 92114028 A TW92114028 A TW 92114028A TW I339125 B TWI339125 B TW I339125B
Authority
TW
Taiwan
Prior art keywords
weight
aqueous solution
acid
polysorbate
ascorbic acid
Prior art date
Application number
TW092114028A
Other languages
Chinese (zh)
Other versions
TW200408633A (en
Inventor
Dariush Behnam
Original Assignee
Aquanova German Solubilisate Technologies Agt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02026130A external-priority patent/EP1338271B1/en
Application filed by Aquanova German Solubilisate Technologies Agt Gmbh filed Critical Aquanova German Solubilisate Technologies Agt Gmbh
Publication of TW200408633A publication Critical patent/TW200408633A/en
Application granted granted Critical
Publication of TWI339125B publication Critical patent/TWI339125B/en

Links

Landscapes

  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Ϊ339125 五、發明說明(1) 一、 【發明所屬之技術領域】 本發明係關於一種抗壞血酸水溶液。 一種如抗壞血酸之還原酮其在工業上的用途,尤其是 在個人衛生與食物營養成分方面,以及其在預防性的運用 上,經常變得非常困難,因為水溶液中抗壞血酸穩定性不 足’因此’水性抗壞血酸溶液,3 0天後其中依然存在的添 加抗壞血酸僅約為7 〇 %。 為此’吾人嘗試改進穩定性,不用抗壞血酸而以改用 才/U壞血酸之衍生物中一種’例如:填抗壞血酸鈉或抗壞血 酸棕糊酸酯代替之。水溶液中活性物質含量很長一段時間 歲乎全部保留住。然而’比較純抗壞血酸衍生物價格上要 \貴好幾倍’此外,於較高的濃度下抗壞血酸衍生物易結晶 化而導致最終產品著色。 二、 【先前技術】Ϊ339125 V. INSTRUCTION DESCRIPTION (1) 1. TECHNICAL FIELD OF THE INVENTION The present invention relates to an aqueous solution of ascorbic acid. A commercially available use of a reducing ketone such as ascorbic acid, especially in terms of personal hygiene and food nutrition, and its use in preventive use, often becomes very difficult because of insufficient stability of ascorbic acid in aqueous solutions. Ascorbic acid solution, the ascorbic acid still present in about 30 days was only about 7 〇%. To this end, we have tried to improve the stability, instead of using ascorbic acid, instead of using one of the derivatives of U-ascorbic acid, for example, sodium ascorbate or ascorbyl acid paste. The active substance in the aqueous solution is kept for a long time. However, the price of a relatively pure ascorbic acid derivative is several times higher. In addition, at a higher concentration, the ascorbic acid derivative is easily crystallized to cause coloration of the final product. Second, [prior art]

,中抗壞血酸之穩定性 β ^歐洲專利說明書第660676號得知一種含有〇, 1至2. 0 重S %且以著色類胡蘿萄素為佳的油溶性紐成分,2至20重 1 0至1 8的乳化劑及〇 · 1至1. 〇重量%^充氧化 可為、聚山梨酸酯4 0或6 0,南抗壞血酸則為 匕一種。如此,利用此一工藝方法應能製 丨屯淨、穩定性飲料。然而,有關最終產品, the stability of ascorbic acid β ^ European Patent Specification No. 660676 is known to contain a bismuth, 1 to 2.0 weight S% and a coloring class of carotenoids oil-soluble New Zealand ingredients, 2 to 20 weight 1 0 The emulsifier and 〇·1 to 1. 〇 % ^ ^ 充 充 充 充 、 、 、 、 聚 聚 聚 聚 聚 聚 聚 聚 聚 聚 聚 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 Thus, the use of this process should be able to produce a clean, stable beverage. However, about the final product

【發明内容】[Summary of the Invention]

!,·乃在於提供抗壞血酸具有一種流體、水 •形態(例如:膠質膠囊)。抗壞血酸穩定 ,1339125 五、發明說明(2) 性可維持多個月不.變’並且可以高濃度形式取得。 根據本發明’達成其目的係在於一種抗壞企酸水溶液 含有HLB值為9至1 8的過量乳化劑,例如:一種聚山梨酸 酯,而以聚山梨酸酯8 0為佳。於室溫下溶液純淨,幾乎是 呈凝膠體,可用水稀釋溶液而不會變渾濁,且當加熱至大 約35C時在毋須進一步處理步驟下,可毫無困難地與取自 化粧品或食品領域的水狀液或脂肪族製成品均勻混合。根 據本發明,溶液中抗壞血酸的部分可多達2 〇重量%,係可 保存至少半年以上而幾乎無損失。至於聚山梨酸酯部分實 際約為6 0重量% ’剩餘部分為水。根據本發明,可將抗壞 ▲酸加溶物輕易地添加至化粧品(膚、髮保養品),食品, 藥物、藥劑及營養溶液内用於繁殖細胞及細菌的培養以及 用在海藻(微藻類),其結果是製品的穩定性得到重大提 1¾ 0 抗壞血酸係於加溶物中以微團形態而可利用者,於電 子顯微鏡下檢查以1 : 1 0 0 0比例稀溶液中的丨0 %抗壞血醆加 溶物時’顯出微團直徑約為100毫微米(nm>由於微困的 乳化劑被膜僅以遲發(延遲方式)釋放所含抗壞血酸,上述 溶劑中根據本發明加溶物之抗氡化效應在與增溶化的遇合 生育酚(維生素E)結合而與例如:抗壞血酸棕櫚酸酯, 即,先前所述之抗壞血酸衍生物中一種比較效應維持較長 久。 至於營養的生理學方面,在口服本發明之加溶物期 間,由乳化劑進行抗壞血酸之微團化作用(micellati〇n) 1339125 五、發明說明(3) 可防止抗壞血酸發生效應並在中央消化道,即:胃及十二 指腸内已被消耗掉。經微團化抗壞▲酸乃是在小腸襄最先 被吸回。 在一項本發明特佳的實施例裏,抗壞血酸加溶物乃包 括增加生月紛’尤其是一種α _、冷_、γ -及占—生育盼( 維生素E)的混合。透過對有機油,例如:.植物油諸如:向 日葵油’莉油,亞麻籽油等加入以上抗壞血酸生育酚加溶 物,可大大改進以上溶劑之穩定性。作為生育酚,可考慮 純α -生育盼抑或一種特別最佳的〇;-、冷-、γ _及5 一生 育酚混合物。建議的混合生育酚為包含約8. 〇至約2〇. 〇%重 量%的α -生育盼,約1. 5至4. 5重量%的沒一生育酚,約55. 〇 至約7 0 · 0重量%的γ _生育酚及約丨5. 〇至約2 7. 〇重量%的占— 生育酚。 若是按本發明的溶液中加入,例如:呈α _次亞麻 (仁)油酸、γ -次亞麻油酸、亞麻油酸或油酸形態的十八 碳三烯酸及/或十八烯酸,溶液的黏度減弱。顯然,於室 溫下攙水可使黏性在無渾濁情況下得到稀釋或黏性溶'液\ 毋須進一步處理步驟憒形下而可與水狀及/或脂肪族營養 品 '化粧品及藥呤相混合。根據本發明溶液中的聚山S梨酸 酯含莖’為軟膏及類似製劑之一般可輕易氧化組成分^!,· is to provide ascorbic acid with a fluid, water • form (for example: gelatin capsules). Ascorbic acid is stable, 1339125 V. Description of the invention (2) Sex can be maintained for many months without change and can be obtained in a high concentration form. According to the present invention, the object is to provide an aqueous solution of an acid resistant acid having an excess emulsifier having an HLB value of from 9 to 18, for example, a polysorbate, and preferably a polysorbate 80. The solution is pure at room temperature and is almost a gel. The solution can be diluted with water without becoming turbid, and when heated to about 35 C, without further processing, it can be taken without difficulty from the cosmetic or food field. The aqueous liquid or the aliphatic product is evenly mixed. According to the present invention, the portion of ascorbic acid in the solution can be as much as 2% by weight, and can be stored for at least half a year with almost no loss. As for the polysorbate portion, it is actually about 60% by weight. The remainder is water. According to the present invention, the anti-bad ▲ acid solubilized product can be easily added to cosmetics (skin, hair care products), food, medicine, pharmaceutical and nutrient solution for breeding of cells and bacteria, and for use in seaweed (microalgae) As a result, the stability of the product is greatly improved. The ascorbic acid is available in the form of micelles in the solubilized solution, and the 丨0% in the dilute solution of 1:100 ratio is examined under an electron microscope. When the ascorbic acid is solubilized, the diameter of the micelles is about 100 nm (nm). Since the emulsifier film which is slightly trapped releases the ascorbic acid only in a delayed (delayed manner), the above solvent is solubilized according to the present invention. The anti-sputum effect of the substance is combined with solubilized tocopherol (vitamin E) and, for example, ascorbyl palmitate, that is, a previously described ascorbic acid derivative is maintained for a longer period of time. In the aspect of the present invention, during the oral administration of the solubilizate of the present invention, the assimilation of the ascorbic acid by the emulsifier (micellati〇n) 1339125 5, the invention description (3) can prevent the ascorbic acid from taking effect It should be consumed in the central digestive tract, that is, in the stomach and duodenum. The micro-agglomerate is the first to be sucked back in the small intestine. In a particularly preferred embodiment of the invention, ascorbic acid Solubilized matter includes an increase in the mixture of the raw moons, especially a mixture of α _, cold _, γ - and occupant - vitamin E. Through the organic oil, for example: vegetable oil such as: sunflower oil 'lily oil, The addition of the above ascorbic acid tocopherol solubilized with linseed oil can greatly improve the stability of the above solvents. As a tocopherol, pure α-fertility or a particularly optimal 〇;-, cold-, γ_ and 5 can be considered. a tocopherol mixture, the recommended mixed tocopherol is from about 8. 〇 to about 2 〇. 〇% by weight of α-probiotics, about 1.5 to 4. 5 wt% of no tocopherol, about 55. 〇 to about 70% by weight of γ-tocopherol and about .5. 〇 to about 2 7. 〇% by weight of tocopherol. If added to the solution according to the invention, for example: α _ sub-linen (ren) oleic acid, gamma-linolenic acid, linoleic acid or oleic acid in the form of octadecatrienoic acid and / or octadecenoic acid, the viscosity of the solution is weakened. Obviously, the water can be diluted or viscous in the absence of turbidity at room temperature, without further processing steps. And / or aliphatic nutritional products 'cosmetic and drug mixture mixed. According to the invention, the polysodium succinate containing stem 'is an ointment and similar preparations can generally be easily oxidized composition ^

產生一種抗壞企酸保守特性的滯後功能類型,因而^ =血 酸有利的保護功能時間得於保留延長。溶液中抗壞二== 量有效可在5重量%至約15重量%之間,溶液以含有約3 量%至約20重量%的十八碳三烯酸及/或十八烯酸最為SA type of hysteresis function that produces a conservative property against bad acid is produced, and thus the beneficial protective function time of the blood acid is retained and prolonged. The amount of anti-bad two == in the solution can be between 5% and about 15% by weight, and the solution contains from about 3% to about 20% by weight of octadecatrienoic acid and/or oleic acid.

1339125 五、發明說明(4) 利。聚山梨酸酯部分則以約60重量%至約75重量%為佳9 若是將溶液中水的比例減到約5重量%至約7重量%之 間,而相應地聚山梨酸酯比例則提高,於室溫下呈現黏性 的溶液也同樣可與活性物質相混合。之後,將混合物質填 入明膠膠囊或不含明膠膠囊内。由於溶液中水的比例很 低,使膠囊殼完好無損,這樣,抗壞血酸對活性成分的保 護功能完好無損。 依照本發明一項製造溶液的程序乃是將一種HLB值約 為9至1 8的乳化劑,一種聚山梨酸酯例如:以聚山梨酸酯 8 0有效,加入到水狀坑壞血酸溶液中,混合物經攪拌短暫 加熱直到變成純淨、均勻。溶液中微團形成及具有直徑約 為1 OOnm,使顯出一種徑向定向聚山梨酸酯分子的雙壁包 層,從而内殼的聚山梨酸酯分子經調準後彼等親水段乃朝 向抗壞血酸溶液,而在外殼中的聚山梨酸酯分子親水段則 是排成向外。以此方法取得的溶液可攙水稀釋而不會變渾 濁且可工業上採用毋須進一步處理步驟。 如果在一項本發明的進一步發展中,將一種主要由甘 油三酸酯組成的輕天_然油,例如:莉子油連同乳化劑加入 到水性抗壞血酸溶液時,微團穩定性增加。而因此形成之 油微困乃黏附並保護抗壞血酸微團。 十八碳三稀酸及/或十八烯酸,例如:α -次亞麻油 酸,Τ -次亞麻油酸,亞麻油酸或油酸的形態下,係在實 際加入聚山梨酸酯之前些微加熱至約5 (TC之後加入到溶液 裏關於填充膠囊,其囊殼由明膠構成或囊殼可以不含明1339125 V. Description of invention (4) Benefit. The polysorbate portion is preferably from about 60% by weight to about 75% by weight. If the proportion of water in the solution is reduced to between about 5% by weight and about 7% by weight, the proportion of polysorbate is increased accordingly. The solution which exhibits viscosity at room temperature can also be mixed with the active substance. Thereafter, the mixture is filled in gelatin capsules or gelatin-free capsules. Since the proportion of water in the solution is low, the capsule shell is intact, so that the ascorbic acid protects the active ingredient intact. A procedure for preparing a solution according to the present invention is to use an emulsifier having an HLB value of about 9 to 18, a polysorbate such as polysorbate 80, added to a hydrous septic acid solution. The mixture is heated briefly by stirring until it becomes pure and homogeneous. The formation of micelles in the solution and having a diameter of about 1000 nm, which results in a double-walled cladding of a radially oriented polysorbate molecule, such that the polysorbate molecules of the inner shell are aligned and their hydrophilic segments are oriented The ascorbic acid solution, while the hydrophilic segments of the polysorbate molecules in the outer shell are arranged outward. The solution obtained in this way can be diluted with water without turbidity and can be industrially employed without further processing steps. In a further development of the invention, the stability of the micelles is increased when a lightly oily oil consisting essentially of triglyceride, for example, prunus oil, together with an emulsifier, is added to the aqueous ascorbic acid solution. The resulting oil is slightly trapped and adheres to and protects the ascorbic acid micelles. Octadecyl tribasic acid and/or octadecenoic acid, for example, α-linolenic acid, quinone-linolenic acid, linoleic acid or oleic acid, before the actual addition of polysorbate Heat to about 5 (after TC is added to the solution for filling the capsule, the capsule is made of gelatin or the capsule can be free of

1339125 五、發明說明(5) 膠,若將抗壞血酸溶解於同量的蒸餾水中,於些微加熱下 加入相同量或加入最高達二倍的和坑壞血酸同樣多的脂肪 酸以及加入聚山梨酸酯8 0大約二至約三倍的量,合劑加熱 至約8 0°C並攪拌。 四、【實施方式】 以下實施例乃說明本發明内容。 實例1 將2 0克抗壞血酸完全溶解於2 0克已脫氣蒸餾過水中。 如是將水加熱至大約4 5°時則可加速溶解階段。之後,溶 液在攪拌及加熱至大約8 0°C下將6 0克聚山梨酸酯8 0加入其 中。攪拌一直到加添物變得清澈、均勻為止,於室溫下加 添物顯得清晰幾乎成凝膠狀,可於水中稀釋而不會引起渾 濁,並且不需進一步加工處理步驟就可添加於欲保藏的組 成物或食品、飲料、化粧品及藥劑中。 對於濃度較低的加溶物,將1 0克抗壞血酸溶解在1 0克 蒸餾水中並加入8 0克聚山梨酸酯,剩下過程與前面所述相 同。從由以上製成之1 0 %抗壞血酸加溶物中加溶物在經攙 水稀釋成1 : 1 0 0 0之後,製作一於第一圖中所複製者電子 顯微圖像。可以看出抗壞血酸加溶物微團的直徑約為1 0 0 毫微米。將加溶物置於石蠟中即可使微團直徑縮減一半, 這可從第一圖中下方的電子顯微圖像裏看出。這種現象可 以解釋為,在石蠟裏微團失去聚山梨酸酯外膜。 實例2 如同實例1,將1 0重量%的抗壞血酸(依據:抗壞血酸1339125 V. Description of the invention (5) Glue, if the ascorbic acid is dissolved in the same amount of distilled water, add the same amount or add up to twice the fatty acid and the polysorbate 8 under the slight heating. 0 about two to about three times the amount, the mixture is heated to about 80 ° C and stirred. 4. Embodiments The following examples are illustrative of the present invention. Example 1 20 g of ascorbic acid was completely dissolved in 20 g of degassed distilled water. If the water is heated to about 45 °, the dissolution phase can be accelerated. Thereafter, 60 g of polysorbate 80 was added to the solution while stirring and heating to about 80 °C. Stir until the added material becomes clear and uniform. The added material appears clear and almost gelatinous at room temperature, can be diluted in water without causing turbidity, and can be added without further processing steps. Preserved composition or food, beverage, cosmetics and pharmaceuticals. For the lower concentration solubilisate, 10 g of ascorbic acid was dissolved in 10 g of distilled water and 80 g of polysorbate was added, and the rest of the process was the same as described above. An electron micrograph of the copy reproduced in the first figure was prepared from the solubilized solution of the 10% ascorbic acid solubilized product prepared above after dilution with hydrazine water to 1:100. It can be seen that the ascorbate solubilized micelles have a diameter of about 100 nm. Place the solubilized material in paraffin to reduce the diameter of the micelle by half, as can be seen from the electron micrograph below in the first image. This phenomenon can be explained by the loss of the polysorbate outer membrane in the paraffin. Example 2 As in Example 1, 10% by weight of ascorbic acid (based on: ascorbic acid)

第8頁 1339125 五、發明說明(6) 加溶物總量=1 0 0 % )溶解於1 0重量%的蒸餾水中,於水溶液 中連同1 〇重量%的輕植物油,諸如:\ϋ或亞麻籽油加入 7 0重量%聚山梨酸酯。然後,將水溶液加熱到至少6 0°C並 搜拌一直到加溶物變得清澈、均勻,室溫下加溶物在水中 溶解透明且無殘餘物。 如果抗壞血酸含量縮減到大約7重量%,含水量同樣亦 減至大約7重量%,而有關加溶物其他比率則因此增加時, 由於水的比率較低之故,而尤其適當可被用於作為延遲製 劑而必要予以封裝之活性物資用之防腐劑。膠囊套則是實 際上完全沒有受到預期會具有高含水量加溶物的侵蝕。 實例3 將1 0克抗壞血酸溶解於1 0克蒸餾水中,溶液中加入2 0 克I,_渔_ .。於此一混合物中加入1 1 〇克聚山梨酸酯8 0,將整 個攪拌、約1 0 0°C時加熱到全無水份為止,即:一直到沸 騰終止。待將溶液冷卻至室溫後,增溶劑裏即出現6. 5 °/成 壞血酸加溶物,加溶物含水量毫無疑問是低於5容積%,且 具有水中可溶性以及脂、油中可溶性。檢驗溶液中抗壞血 酸含量,係由一獨立、的化學檢驗實驗室於溶液產生之當時 以及超過5個月時間内進行,檢驗結果顯示,整個該階段 内抗壞血酸損失僅約為3%。 實例4 本實例起動點,係為一項根據實例2的加溶物。加溶 物中加入一種由以下方式所製成之混合生育酚加溶物。使 1 0重量%混合生育酚(依據:混合生育酚加溶物=1 0 0重量%) 1339125 五、發明說明(7) 藉由攪拌與9 0重量%聚山梨酸酯2 0混合,從而利用加熱至 約6 0°C方式加速混合過程。繼續攪#直到混合物清澄透 明,加溶物可輕易地溶解於水中為止。有關混合生育酚, 本案建議加入91毫克/克α -生育酚的混合生育酚,21毫克 /克/3 -生育酚的混合生育酚,6 0 8毫克/克r -生育酚的混 合生育酚及209毫克/克<5 -生肓酚的混合生育酚。 而後,按照實例2中的第一替代方案,將3重量分加溶 物與約7重量分混合生育酚加溶物混合,從而輕微加熱至 約5 0°C即可加速混合過程。在加熱中進行攪拌直到均勻及 清澄的加溶物產生為止。如此,1克產品中含有約7 0毫克 的混合生育酚以及3 0毫克抗壞血酸。本實例加溶物,作為 一種有效抗氧化劑可用於改進食品染料,油,化粧品,藥 品及類似產品的穩定性。 比較試驗顯示,無關於最終產生(親水性或疏水性的 特徵,可使本實例加溶物直接合併入最終產品内無需中間 生產階段,且提供較同量的取自一種抗壞血酸衍.生物,諸 如舉例:抗壞血酸棕橺酸酯的抗壞血酸更佳的防氧化作 用。又,比較抗壞血酸衍生物,加溶物中較無色素這一點 也有利。此外,視要求而定,約1 0 0 0克最終產生品中可加 入,例如:1至1 0克加溶物。 從營養的觀點來看,本實例加溶物的一項生理學上優 點乃在於,胃酸中微團穩定性佳且可確保抗壞血酸(維生 素C)與(採用α -生育酚)維生素E全無損耗地到達小腸並在 小腸内被吸收掉。此一優點亦可利用在其他維生素上,例Page 8 1339125 V. Description of the invention (6) Total amount of solubilized material = 100%) dissolved in 10% by weight of distilled water in an aqueous solution together with 1% by weight of light vegetable oil such as: \ϋ or flax The seed oil was added to 70% by weight of polysorbate. Then, the aqueous solution is heated to at least 60 ° C and mixed until the solubilized material becomes clear and homogeneous, and the solution is dissolved in water to be transparent and free of residue at room temperature. If the ascorbic acid content is reduced to about 7% by weight, the water content is also reduced to about 7% by weight, and the other ratios of the solubilized material are increased, because the ratio of water is low, and particularly suitable for use as A preservative that delays the formulation and is necessary to encapsulate the active material. The capsule sleeve is virtually completely eroded by the expected high water content solubilization. Example 3 10 g of ascorbic acid was dissolved in 10 g of distilled water, and 20 g of I, _fishing_. was added to the solution. To this mixture was added 1 1 gram of polysorbate 80, and the whole was stirred and heated to about 100 ° C to the whole anhydrous portion, i.e., until the boiling was terminated. After the solution is cooled to room temperature, 6. 5 ° / ascorbic acid solubilisate appears in the solubilizer, the water content of the solubilized solution is undoubtedly less than 5% by volume, and has water solubility and fat, oil Medium soluble. The ascorbic acid content of the test solution was carried out by an independent chemical laboratory at the time of solution generation and over a period of 5 months. The test results showed that the ascorbic acid loss was only about 3% throughout this period. Example 4 The starting point of this example is a solubilized material according to Example 2. A mixed tocopherol solubilized product prepared in the following manner is added to the solubilized material. 10% by weight of mixed tocopherol (based on: mixed tocopherol solubilizer = 1.0% by weight) 1339125 V. Description of the invention (7) By stirring and mixing with 90% by weight of polysorbate 20, Heating to about 60 °C speeds up the mixing process. Continue to stir until the mixture is clear and clear, and the solubilized material can be easily dissolved in the water. For mixed tocopherols, it is recommended to add 91 mg/g of α-tocopherol mixed tocopherol, 21 mg/g/3-tocopherol mixed tocopherol, 608 mg/g r-tocopherol mixed tocopherol and Mixed tocopherol of 209 mg/g <5-sodium phenol. Then, according to the first alternative in Example 2, 3 parts by weight of the solution was mixed with about 7 parts by weight of the mixed tocopherol solubilized, thereby slightly heating to about 50 ° C to accelerate the mixing process. Stirring is carried out under heating until a homogeneous and clear solubilized material is produced. Thus, 1 gram of product contains about 70 mg of mixed tocopherol and 30 mg of ascorbic acid. The present example solubilized material, as an effective antioxidant, can be used to improve the stability of food dyes, oils, cosmetics, pharmaceuticals and the like. Comparative tests have shown that no matter what is ultimately produced (hydrophilic or hydrophobic), the present solution can be directly incorporated into the final product without intermediate production stages, and provides a greater amount of an ascorbic acid derived organism, such as For example: ascorbic acid ascorbate has better anti-oxidation effect. Moreover, it is also advantageous to compare ascorbic acid derivatives with less pigment in the solubilized solution. In addition, depending on the requirements, about 1 000 g is finally produced. The product may be added, for example, from 1 to 10 g of solubilized material. From a nutritional point of view, a physiological advantage of the solubilized material of the present example is that the micelle stability in gastric acid is good and ascorbic acid is ensured ( Vitamin C) and (with α-tocopherol) vitamin E reach the small intestine without loss and is absorbed in the small intestine. This advantage can also be used in other vitamins, for example

第10頁 1339125 五、發明說明(8) 如:視黃醇(維生素A)與召-胡蘿蔔素,且可以下例一種包 括多種維生素組成之製劑而取得:_ 實例5 將2 0重量%的a -生育酚於約5 0°C時所必要的熱度下與 8 0重量%的聚山梨酸酯2 0相混合直到透過攪拌混合物變得 清澄、透明與均勻為止。 以相同方式使1 0重量%的視黃醇與9 0重量%的加溶物8 0 相混合。 最後,以一適當的方式使1 0重量%含約3 0 -胡蘿蔔Page 10 1339125 V. Description of the invention (8) For example: retinol (vitamin A) and phyto-carotene, and can be obtained as follows: a preparation comprising a multivitamin composition: _ Example 5 20% by weight of a Tocopherol is mixed with 80% by weight of polysorbate 20 at a heat necessary at about 50 ° C until it becomes clear, transparent and homogeneous by stirring the mixture. 10% by weight of retinol was mixed with 90% by weight of solubilized material 80 in the same manner. Finally, in a suitable way, 10% by weight contains about 30-carrots.

素(可得自La Roche公司)的濃縮物與90重量%聚山梨酸酯 8 0相混合以形成一種紅棕色透明的加溶物,加溶物明顯地 溶解於溫水中。The concentrate (available from La Roche) was mixed with 90% by weight of polysorbate 80 to form a reddish brown transparent solubilized material which was clearly dissolved in warm water.

隨後,將8 5重量%根據實例2中第一項選擇式之抗壞血 酸加溶物與1 0重量%之上述<2 -生育盼加溶物及與2重量%之 上述視黃醇加溶物以及最後3重量%之/5 -胡蘿蔔素加溶物 於微熱攪拌下有效相混合直到一項均勻並透明混合加溶物 獲得為止。此種水溶性維生素加溶物可封裝於明膠膠囊或 不含明膠的膠囊内,或於無需增添處理步驟即可將維生素 加溶物直接併入到水溶性及/或脂溶性最終產品裏。 根據本發明之維生素加溶物,與乳狀液或脂質體截然 不同,當放置到水中及/或澄澈果汁中時即形成穩定、清 澄的溶液。產品微團於胃酸中穩定性佳。對微團内的脂溶 物質 '諸如:維生素A,維生素E及/3 -胡蘿蔔素的吸收, 係發生在小腸内並無涉及膽汁鹽及酵素。因此,本件微團Subsequently, 85 wt% of the ascorbic acid solubilized according to the first choice in Example 2 and 10% by weight of the above <2 - fertility solubilized solution and 2% by weight of the above retinol solubilized product And the last 3 wt% of the/5-carotene solubilized material is effectively mixed under gentle agitation until a homogeneous and transparent mixed solubilized material is obtained. The water-soluble vitamin solubilizer can be enclosed in gelatin capsules or gelatin-free capsules, or the vitamin solubilized product can be directly incorporated into the water-soluble and/or fat-soluble end product without additional processing steps. The vitamin solubilisate according to the present invention, unlike emulsions or liposomes, forms a stable, clear solution when placed in water and/or clear juice. The product micelles have good stability in gastric acid. The absorption of fat-soluble substances in the micelles such as vitamin A, vitamin E and /3 - carotene occurs in the small intestine and does not involve bile salts and enzymes. Therefore, this piece of micelle

第11頁 1339125 五、發明說明(9) 形狀中所引證之活性物質係能更加快速地於生物上獲得 者。 ' 1克具有前述組成的維生素加溶物,併入到食品中或 封裝膠囊即可補給人體每日必要的維生素A,C,E及/3 -胡蘿 蔔素。引證有前面數字的維生素加溶物的組成係以適應此 一運用而準備者。以上考慮到每日必要的維生素C,事實 上是比對其他維生素的要求要高些。然而,本發明範圍為 維生素加溶物也能選用其他的組成及/或計劃運用裏如果 有某一種維生素需要去除或已無必要時,可完全省略該項 或其他項維生素。 第二、三及四圖顯示α -生育紛加溶物,/3 -胡蘿萄素 加溶物與視黃醇加溶物等的平均微團半徑(或輻射線)。正 如所見,平均微團半徑為1 0毫微米,至於視黃醇加溶物則 是下降至正好約為8毫微米。全部測量係採用由懷亞特科 技(Wyatt Technologies)所製之電場流量分級(field flow fractionation)進行。第五圖顯示一維生素A微團之 電子顯微鏡影像,第六圖為一維生素E微團之電子顯微鏡 影像。試樣為前面所述之加溶物的1 : 1 0 0 0水溶液。Page 11 1339125 V. INSTRUCTIONS (9) The active substances cited in the shape are more rapidly bioacquired. '1 gram of vitamin solubilized material of the aforementioned composition, incorporated into food or encapsulated capsules can replenish the daily essential vitamins A, C, E and /3 - carotene. The composition of the vitamin solubilized material with the previous figures is cited to prepare for this application. Taking into account the daily essential vitamin C, the fact is higher than the requirements for other vitamins. However, the scope of the present invention is that the vitamin solubilizing agent can also be selected from other compositions and/or intended use. If a certain vitamin needs to be removed or is not necessary, the vitamin or other vitamin may be omitted altogether. The second, third and fourth graphs show the average micelle radius (or radiation) of α-fertility solubilized, /3 - guaranin solubilisate and retinol solubilized. As can be seen, the average micelle radius is 10 nanometers, and the retinol solubilisate is reduced to just about 8 nanometers. All measurements were performed using field flow fractionation by Wyatt Technologies. The fifth image shows an electron microscope image of a vitamin A micelle, and the sixth image shows an electron microscope image of a vitamin E micelle. The sample was a 1:1000 aqueous solution of the solubilized solution described above.

1339125 圖式簡單說明 ~~~- ~ 第 圊顯示維生素c成品微團圖,為科學界首次可透 過電子顯微鏡攝影所觀測到者(由AQUANOVA委託在德國達 姆施塔特工業大學進行> ° 液態穩定型抗壞也酸之維生素C微困: 1 〇 %抗壞血·酸加添物,稀釋1: 1〇〇〇 上圖a )水中 下圖b)石蠟 石蠟中,雙壁抗壞血酸微團脫除外層殼。 第一、二及四圖顯示01 —生育紛加溶物 ' 冷_胡蘿蔔素 加溶物與視黃醇加溶物等之平均微團半徑(輻射線)圖。 第五圖顯示成品微團圖(由AQUAN〇VA委託在梓國達 施塔特工業大學製作),為首次藉由電子顯微鏡;像於水 溶液(1: 1 0 0 0 )中見到,圖中自左至右:a圖為水溶性 AQUANOVA視黃醇加添物中維生素八微團圖。b圖為 AQUANOVA生育盼加添物中生育酚微團圖。ε圖為一種益料 團基片。 徑…、微 第六圖顯示水溶液中微團AQUAN〇VA維生素E與維生 A加添物之徑向分佈圖。 μ1339125 Simple description of the figure ~~~- ~ The third part shows the micro-cluster map of vitamin C, which is the first time that the scientific community can observe through electron microscopy (authorized by AQUANOVA at the Technical University of Darmstadt, Germany) Liquid stable anti-adhesive acid vitamin C micro-difficulties: 1 〇% ascorbic acid and acid addition, diluted 1: 1 〇〇〇 above a) Under water b) Paraffin paraffin, double-walled ascorbic acid micelle Remove the outer shell. The first, second and fourth graphs show the mean microsphere radius (radiation) of 01 - fertility plus dissolved matter 'cold_carotene solubilisate and retinol solubilized matter. The fifth picture shows the finished micro-cluster map (produced by AQUAN〇VA at the Da Shitat University of Technology in Laos) for the first time by electron microscopy; as seen in aqueous solution (1:1 0 0 0), in the figure From left to right: a picture is a figure of vitamin eight micro-clusters in water-soluble AQUANOVA retinol added. Figure b is a graph of tocopherol micelles in AQUANOVA. The ε image is a probiotic substrate. Path..., micro Figure 6 shows the radial distribution of the micelle AQUAN〇VA vitamin E and the vitamin A addition in the aqueous solution. μ

Claims (1)

1339125 , ' 〇'::以 六、申請專利範圍 1 · 一種抗壞血酸之水溶液,含有HLB值約為9至1 8之過量乳 化劑,該水溶液所含抗壞血酸含量最高約為2 0重量%, 所含乳化劑是含量約為6 0至8 0重量%範圍内的聚山梨酸 酯,其餘的則是水;該水溶液係作為添加劑,用在各種 食品、化粧品、藥物藥劑以及用於細胞及細菌培養或藻 類培養之營養液中。 2. 如申請專利範圍第1項之水溶液,該水溶液含有聚山梨 酸酯8 0作為乳化劑。 3. 如申請專利範圍第1項或第2項之水溶液,該水溶液添加 α -生育酌·。 4. 如申請專利範圍第1項或第2項之水溶液,該水溶液添加 混合生育酚。 5 .如申請專利範圍第4項之水溶液,該水溶液的混合生育 酚含有約8. 0至2 0 . 0重量%的α -生育酚、約1. 5至4. 5重 量%的/3 -生育酚、約55. 0至約為70. 0重量%的7 -生 育酚及約為15.0至27.0重量%的5 -生育酚。 6.如申請專利範圍第1至5項中任一項之水溶液,該水溶液 含有十八碳三烯酸及/或十八烯酸。 7 .如申請專利範圍第6項之水溶液,該水溶液含有1 0至2 0 重量%的十八碳三稀酸及/或十八稀酸成分。 8. 如申請專利範圍第6項之水溶液,該水溶液包含: α -亞麻油酸、γ -亞麻油酸、亞麻油酸或油酸。 9. 如申請專利範圍第1項之水溶液,該水溶液之抗壞血酸 含量為1 0重量%、水含量為1 0重量%以及聚山梨酸酯8 01339125 , ' 〇 ':: 6-1, patent application range 1 · An aqueous solution of ascorbic acid containing an excess of emulsifier having an HLB value of about 9 to 18, the aqueous solution containing ascorbic acid content of up to about 20% by weight, including The emulsifier is a polysorbate in the range of about 60 to 80% by weight, and the rest is water; the aqueous solution is used as an additive in various foods, cosmetics, pharmaceutical agents, and for cell and bacterial culture or In the nutrient solution of algae cultivation. 2. The aqueous solution of claim 1, wherein the aqueous solution contains polysorbate 80 as an emulsifier. 3. If the aqueous solution of claim 1 or 2 is applied, the aqueous solution is added with α-fertility. 4. If the aqueous solution of claim 1 or 2 is applied, the aqueous solution is mixed with tocopherol. 5至4. 5重量%的/3 - 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 Tocopherol, from about 50.5 to about 70.0% by weight of 7-tocopherol and about 15.0 to 27.0% by weight of 5-tocopherol. 6. The aqueous solution according to any one of claims 1 to 5, wherein the aqueous solution contains octadecatrienoic acid and/or oleic acid. 7. The aqueous solution of claim 6, wherein the aqueous solution contains 10 to 20% by weight of octadecanoic acid and/or octadecyl acid. 8. The aqueous solution of claim 6, wherein the aqueous solution comprises: alpha-linolenic acid, gamma-linolenic acid, linoleic acid or oleic acid. 9. If the aqueous solution of claim 1 is applied, the aqueous solution has an ascorbic acid content of 10% by weight, a water content of 10% by weight, and a polysorbate 80. 第14頁 1339125 六、申請專利範圍 含量為80重量%。 1 0 .如申請專利範圍第1項之水溶液,該水溶液之抗壞血酸 含量為1 0重量%、水含量為1 0重量%,並有含量為1 0重 量%的輕植物油,其包括莉子油、亞麻油、以及含量 為70重量%的聚山梨酸酯80。 1 1.如申請專利範圍第1 0項之水溶液,該水溶液含有三個 重量部份的溶液及七個重量部分的混合生育酚增溶 物,其中增溶物含有1 0重量%的混合生育酚以及9 0重 量%的聚山梨酸酯2 0。 1 2 .如申請專利範圍第1 1項之水溶液,該水溶液含有8 5重 量%的溶液、10重量%的<2 -生育紛增溶物(加溶 物)、2重量%的維生素A增溶物以及3重量%的冷-胡 蘿蔔素增溶物;其中α -生育酚增溶物含有2 0重量% 的α -生育酚與8 0重量%的聚山梨酸酯20,維生素Α增 溶物含有1 0重量%的維生素A與9 0重量%的聚山梨酸酯 80,而泠-胡蘿蔔素增溶物含有90重量%的聚山梨酸 酯8 0與1 0重量%的濃縮液,且該濃縮液中含有3 0重量% 的/3 -胡蘿蔔素。 1 3 .如申請專利範圍第3或4項之水溶液,該水溶液係作為 葵花油、薊子油、亞麻油之有機油類的添加物來使 用。 1 4.如申請專利範圍第1 2項之水溶液,該水溶液係作為膠 囊的填充物、或是作為果汁的添加物來使用。 1 5.如申請專利範圍第1項之水溶液,該水溶液含有1 0重量Page 14 1339125 VI. Patent application The content is 80% by weight. 1 0. The aqueous solution of claim 1, wherein the aqueous solution has an ascorbic acid content of 10% by weight, a water content of 10% by weight, and a content of 10% by weight of light vegetable oil, including plum oil, Sesame oil, and polysorbate 80 in an amount of 70% by weight. 1 1. An aqueous solution according to claim 10, wherein the aqueous solution contains three parts by weight of a solution and seven parts by weight of a mixed tocopherol solubilizing agent, wherein the solubilizing substance contains 10% by weight of mixed tocopherol And 90% by weight of polysorbate 20. 1 2 . The aqueous solution of claim 1 of the patent scope, the aqueous solution containing 85 wt% of the solution, 10 wt% of < 2 - fertility solubilisate (solubilized matter), 2 wt% of vitamin A increase a solution and a 3% by weight cold-carotene solubilizate; wherein the α-tocopherol solubilizate contains 20% by weight of α-tocopherol and 80% by weight of polysorbate 20, and the vitamin Α solubilizer Containing 10% by weight of vitamin A and 90% by weight of polysorbate 80, and the ruthenium-carotene solubilizer contains 90% by weight of polysorbate 80 and 10% by weight of concentrated liquid, and The concentrate contains 30% by weight of /3 - carotene. An aqueous solution of the third or fourth aspect of the patent application is used as an additive for organic oils of sunflower oil, hazelnut oil, and linseed oil. 1 4. An aqueous solution according to claim 12, which is used as a filling for a capsule or as an additive for fruit juice. 1 5. The aqueous solution of claim 1 of the patent scope, the aqueous solution contains 10 weight 第15頁 1339125 六、申請專利範圍 %的抗壞血酸、1 0重量%的水、2 0重量%的薊子油, 以及11 0重量%的聚山梨酸酯8 0。 1 6. —種製備如申請專利範圍第1項之抗壞血酸水溶液之方 法,該方法包括:於該水溶液中加入聚山梨酸酸,並 將混合物於微熱下適當攪拌直到其變得清澈透明且均 勻之步驟。 1 7 .如申請專利範圍第1 6項之製備方法,該方法包括:直 接於該水溶液中加入聚山梨酸酯8 0之步驟。 18.如申請專利範圍第16項之製備方法,該方法包括:於 該水溶液中加入一種主要成分為甘油三醋的自然油, 且同時混合乳化劑之步驟。 1 9 .如申請專利範圍第1 8項之製備方法,該方法包括:即 於該水溶液中加入薊子油之步驟。 2 0 .如申請專利範圍第1 6至1 9項之製備方法,該方法包 括:於該水溶液中加入聚山梨酸酯之前並經攪拌中輕 微加熱至約5 0°C之後,加入十八碳三烯酸及/或十八 烯酸之步驟。 2 1.如申請專利範圍第2 0項之製備方法,該方法包括:即 於該水溶液中加入呈α -亞麻油酸、7 -亞麻油酸、 亞麻油酸或油酸形式之十八碳三烯酸及/或十八烯酸 之步驟。 2 2.如申請專利範圍第1 7項之製備方法,該方法包括:使 2 0重量%之抗壞血酸溶解於2 0重量%之水中,接著將 6 0重量%之聚山梨酸酯8 0經攪拌並加熱至約8 0°C之後Page 15 1339125 VI. Patent application range % ascorbic acid, 10% by weight of water, 20% by weight of hazelnut oil, and 11% by weight of polysorbate 80. 1 6. A method for preparing an aqueous solution of ascorbic acid according to claim 1, wherein the method comprises: adding polysorbic acid to the aqueous solution, and stirring the mixture under mild heat until it becomes clear and uniform. step. 17. The preparation method of claim 16, wherein the method comprises the step of adding polysorbate 80 directly to the aqueous solution. 18. The preparation method according to claim 16, wherein the method comprises the steps of: adding a natural oil having a main component of triacetin to the aqueous solution, and simultaneously mixing the emulsifier. 19. The preparation method of claim 18, wherein the method comprises the step of adding eucalyptus oil to the aqueous solution. 2 0. The preparation method of claim 16 to 19, which comprises: adding eighteen carbons before adding the polysorbate to the aqueous solution and slightly heating to about 50 ° C with stirring The step of trienoic acid and/or oleic acid. 2 1. The preparation method according to claim 20, wherein the method comprises: adding to the aqueous solution an 18-carbon three in the form of α-linolenic acid, 7-linolenic acid, linoleic acid or oleic acid. The step of an enoic acid and/or oleic acid. 2 2. The preparation method of claim 17, wherein the method comprises: dissolving 20% by weight of ascorbic acid in 20% by weight of water, followed by stirring 60% by weight of polysorbate 80 And heated to about 80 ° C 第16頁 1339125 六、申請專利範圍 加入其混合溶液中,然後攪拌直到混合物變得清澈透 明且均勻之步驟。 2 3 ·如申請專利範圍第2 2項之製備方法,該方法包括:為 加速其溶解過程,而將水輕微加熱至約4 5°C之步驟。 2 4 .如申請專利範圍第1 6項中涉及申請專利範圍第1 5項之 抗壞血酸溶液之製備方法,該方法包括:使10重量% 之抗壞血酸溶解於1 0重量%之水中,並於溶液中加入 2 0重量%之薊子油,且添加1 1 0重量%之聚山梨酸酉旨 8 0,加熱至約1 0 0°C並一直攪拌到結束烹煮過程為止之 步驟。Page 16 1339125 VI. Scope of Application The procedure is to add it to its mixed solution and then stir until the mixture becomes clear and homogeneous. 2 3 . The preparation method of claim 2, wherein the method comprises the step of slightly heating the water to about 45 ° C in order to accelerate the dissolution process. 2 . The preparation method of the ascorbic acid solution of claim 15 in the patent application scope, wherein the method comprises: dissolving 10% by weight of ascorbic acid in 10% by weight of water, and in solution 20% by weight of hazelnut oil was added, and 110% by weight of polysorbate sorbate 80 was added, heated to about 1000 ° C and stirred until the end of the cooking process.
TW092114028A 2002-11-23 2003-05-23 Aqueous solution of ascorbic acid and method for producing same TWI339125B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02026130A EP1338271B1 (en) 2001-11-30 2002-11-23 Aqeous solution of ascorbic acid

Publications (2)

Publication Number Publication Date
TW200408633A TW200408633A (en) 2004-06-01
TWI339125B true TWI339125B (en) 2011-03-21

Family

ID=32921570

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092114028A TWI339125B (en) 2002-11-23 2003-05-23 Aqueous solution of ascorbic acid and method for producing same

Country Status (5)

Country Link
CN (1) CN1502325A (en)
AU (1) AU2003204456A1 (en)
BR (1) BR0302860B1 (en)
RU (1) RU2303036C2 (en)
TW (1) TWI339125B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012036743A1 (en) 2010-09-16 2012-03-22 Kalamazoo Holdings, Inc. Stable edible fluid fats and oils and improved ascorbic acid compositions to produce same
CN102323430A (en) * 2011-08-15 2012-01-18 北京利德曼生化股份有限公司 Stable unsaturated iron bonding force determination kit
US20190350233A1 (en) * 2016-08-31 2019-11-21 Chr. Hansen Natural Colors A/S Water-dispersible coloring composition
RU2720516C1 (en) * 2019-07-05 2020-04-30 Государственное бюджетное образовательное учреждение высшего образования Московской области "Университет "Дубна" (Государственный университет "Дубна") Method of producing micellar complexes of copper (ii) using non-ionic surfactants

Also Published As

Publication number Publication date
AU2003204456A1 (en) 2004-06-10
CN1502325A (en) 2004-06-09
RU2303036C2 (en) 2007-07-20
TW200408633A (en) 2004-06-01
BR0302860A (en) 2004-08-24
BR0302860B1 (en) 2015-01-06

Similar Documents

Publication Publication Date Title
Huang et al. Nanostructured lipid carrier (NLC) as a strategy for encapsulation of quercetin and linseed oil: Preparation and in vitro characterization studies
US6774247B2 (en) Aqueous solution of ascorbic acid and method for producing same
US10568843B2 (en) Method of preparing highly stable microcapsule powders or microparticles containing fat-soluble nutrient having increased double bonds
CN103190631B (en) Non-aqueous pre-emulsion composition and preparation comprise the method for the beverage of phytosterol
CN103037708A (en) Nanoemulsion including sucrose fatty acid ester
CN1658770A (en) Nano-sized self-assembled structured liquids
JP2009505809A (en) Emulsifier system, its emulsion and its use
WO2008101344A1 (en) Soluble bioactive lipophilic compounds compositions
CN112399847B (en) Vitamin K2 microcapsule, preparation method thereof and application thereof in preparing medicament for preventing and treating cardiovascular and cerebrovascular diseases
CN108125947A (en) A kind of bio-compatible microemulsion is the dihydromyricetin medicament of carrier, preparation method and application
Wu et al. Nutraceutical delivery systems to improve the bioaccessibility and bioavailability of lycopene: A review
TWI339125B (en) Aqueous solution of ascorbic acid and method for producing same
JP2012131768A (en) Composition and application of carotenoid having improved absorption and bioavailability
JP6234112B2 (en) W / O / W emulsion composition
CN115969807A (en) Soft capsule content containing bioactive components and preparation method thereof
JP6622950B1 (en) Compositions for preparing microemulsions, microemulsions, methods for their production and use of microemulsions
JP3131917U (en) Soft capsule
JP2004189749A (en) Cosmetic composition
Prusty et al. A Review on Oleogels and Its Role in Pharmaceutical Field
JP6533003B1 (en) Carotene-containing oily composition
JP2004175664A (en) Aqueous composition of fat-soluble vitamins, production method and administration method for fat-soluble vitamins
KR20030063019A (en) Emulsive compositions comprising high unsaturated fatty acids and their preparations for micro liquid capsules
JP3557579B2 (en) Soft capsule
JP2024060510A (en) Oily composition and capsule preparation containing same
JP2024011479A (en) Composition including oil and fat component and use thereof, and method for producing the composition

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees